Market revenue in 2022 | USD 1,543.4 million |
Market revenue in 2030 | USD 1,983.1 million |
Growth rate | 3.2% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , UK , Japan , South Africa , Saudi Arabia
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.38% in 2022. Horizon Databook has segmented the U.S. orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
High number of surgical procedures are performed in the country every year. Growing prevalence of lifestyle-related health conditions, rising geriatric population, and favorable government policies are some of the key factors driving the number of surgeries in the country, contributing to market growth.
Furthermore, the U.S. is dominating the market owing to presence of major players such as Stryker, Baxter, and Zimmer Biomet. In February 2020, Anika acquired Arthrosurface to enhance its commercial capabilities, increase revenue, and expand joint preservation & restoration product portfolios, as well as its product pipeline.
While in January 2020, it acquired Parcus Medical a sports medicine implant and instrumentation company thus expanding its soft tissue surgical repair and reconstruction portfolio. These factors support growth of the country’s market.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into U.S. orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account